Hematology Flashcards
α-thalassemia
minima: αα/α- (silent)
Minor: α-/α- or αα/– (mild)
Hemoglobin H disease: α-/– (moderate)
microcytic hypochromic anemia
Asian → cis
African → trans
ß-thalassemia
microcytic, hypochromic anemia
↑ HbA2
Minor → heterozygote
Major → homozygote
Sickle cell
Glutamic acid → Valine on the ß-chain
low O2 and acidosis trigger sickling
HbC disease
Glutamic Acid → Lysine on the ß chain
target cells
Ferritin
primary storage form of iron
Acute Intermittent prophyria
defective porphobilinogen deaminase ↑ porphobilinogen Painful abdomen port wine-colored urine polyneuropathy psychological alcohol, starvation
Porphyria cutanea tarda
defective uroporphyrinogen decarboxylase ↑ Uroporphyrin Blistering skin photosensitivity hyperpigmentation associated with Hep C
↑ PTT
intrinsic pathway defect
↑ PT
Extrinsic pathway defect
Hemophilia ABC
A → factor VIII (8)
B → factor IX (9)
C → factor XI (11)
Hemarthroses
easy bruising
intrinsic pathway defects
Bernard-Soulier
GpIb
platelet-vWF adhesion defect
Glanzmann thrombasthenia
GpIIb/IIIa
platelet-platelet adhesion defect
TTP and HUS
Thombocytopenia + hemolyic anemia + AKI
HUS → hx of bloody diarrhea (commonly EHEC)
TTP → triad + fever + neuro symptoms
→ ADAMTS13
von Willebrand
↓vWF
platelet-vWF adhesion defect
↑ PTT
DIC
disseminated intravascular coagulation
widespread activation of clotting leads to ↓ clotting factors →
bleeding state
Factor V leiden
hypercoagulability
DNA point mutation of guanine → adenine
Hodgkin lymphoma
localized, single group of nodes
Reed-Sternberg cells → owl eyes, CD15, CD30
B-cell origin
EBV
Burkitt lymphoma
Non-Hodgkin lymphoma t(8;14) (c-myc; heavy chain Ig) (Burk8) starry sky Jaw lesions in endemic African version Pelvis or abdomen in sporadic form EBV
Diffuse large B-cell lymphoma
BCL-2, BCL-6
common in adults
Follicular lymphoma
t(14;18) (heavy chain Ig ; BCL-2)
painless waxing and waning lymphadenopathy
Mantle cell lymphoma
t(11;14) (cyclin D1 ; heavy chain Ig)
Males (MANtle)
agressive
Marginal zone
t(11;18) (cyclin D1 ; BCL-2) chronic inflammation (Sjogrens, chronic gastritis)
Primary central nervous system lymphoma
AIDs defining illness
Confusion, memory loss, seizures
ring enhancing brain lesion
Adult T-cell lymphoma
HTLV (IV drug abuse)
Japan, Africa, Caribbean
lytic bone lesions, hypercalcemia
Mycosis fungoides/Sezary syndrome
skin patches and plaques
atypical CD4 cells with cerebriform nuclei
Pautrier microabcesses (cancer cell aggregates in epidermis)
ALL (acute lympoblastic leukemia)
Children asx with Down syndrome TdT+ CD10+ mediastinal mass t(12;21) → better prognosis
CLL (chronic lymphycytic leukemia) aka SLL (small lymphocystic lymphoma)
Age 60+
CD5+
CD20+
CD23+
smudge cells in blood smear (CLL = crushed little lymphocytes)
Richter transformation → CLL/SLL into aggressive lymphoma, usually diffuse large B-cell
Hairy cell leukemia
tumor cells have hair like projections
marrow fibrosis
stains TRAP+
BRAF mutation
AML (acute myelogenous leukemia)
Auer rods: myeloperoxidase + cytoplasmic inclusions
↑↑↑ circulating myeloblasts
age 65
Risk factors:
Down syndrome
exposure to radiation, or chemotherapy
t(15;17) (APL form of AML, asx with Auer rods, responds to all-trans retinoic acid)
CML (Chronic myelogenous leukemia)
age 45-85
t(9;22), BCR-ABL → Philadelphia chromosome
↓ LAP (leukocyte alkaline phosphatase)
EML4-ALK
Langerhans cell histiocytosis
lytic bone lesions + skin rash
recurrent otitis media with mastoid bone mass
Birbeck granules → tennis rackets on EM
S-100
Warfarin
inhibits epoxide reductase in Vit K
↓ factors 2, 7, 9, 10, protein S, protein C
Initially hypercoaguable
Heparin
↑ antithrombin → ↓action of IIa (thrombin) and Xa
Low molecular weight versions are:
enoxaparin, dalteparin → mostly Xa
fondaparinux → only Xa
Bivalirudin
direct thrombin inhibitor
used when HIT occurs
Argatroban
direct thrombin inhibitor
used when HIT occurs
Dabigatran
direct thrombin inhibitor
used when HIT occurs
Apixaban
Direct factor Xa inhibitor
Rivaroxaban
Direct factor Xa inhibitor
ADP receptor inhibitors
Clopidogrel, ticlopidine, ticagrelor, prasugrel block ADP (P2Y12) receptor → ↓expression of glycoproteins IIb/IIIa
Clopidogrel
ADP receptor inhibitors
ticlopidine
ADP receptor inhibitors
ticagrelor
ADP receptor inhibitors
prasugrel
ADP receptor inhibitors
Glycoprotein IIb/IIIa inhibitors
Abciximab, eptifibatide, tirofan
bind to IIa/IIIb on platelets, inhibiting aggregation
Abciximab
Glycoprotein IIb/IIIa inhibitors
eptifibatide
Glycoprotein IIb/IIIa inhibitors
tirofiban
Glycoprotein IIb/IIIa inhibitors
Multiple myeloma
CRAB hyperCalcemia Renal involvement Anemia Bone lytic lesions (punched out lesion)
M spike
↑ Ig → Ig in urine (Bence Jones protein)
Rouleaux formation (RBC stacks)
clock face plasma cells
CD3
T-cell
CD28
T-cell
CD19, 20, 21
B-cell
CD14
macrophage
CD16
NK cell
CD56
NK cell
IL-2
T cells
IL-3
bone marrow stem cells
IL-4
IgE class switching
Tcells → Th2 cells
B cell growth
IL-5
IgA class switching
CYP-450 inducers
Phenytoin Phenobarbital Carbamezapine Rifampin St. John's Wort
↑ drug clearance
CYP-450 inhibitors
Antibiotics (metronidazole, macrolides) Azole Antifungals Amiodarone Cimetidine Grapefruit juice
↑ drug concentration → overdose